Ignite Creation Date:
2024-05-06 @ 2:54 PM
Last Modification Date:
2024-10-26 @ 1:39 PM
Study NCT ID:
NCT04456049
Status:
TERMINATED
Last Update Posted:
2022-08-10
First Post:
2020-07-01
Brief Title:
Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1
Sponsor:
Ricardo Pereira Mestre
Organization:
Ente Ospedaliero Cantonale Bellinzona
Organization Data
Organization:
Ente Ospedaliero Cantonale Bellinzona
Class:
OTHER
Study ID:
COVID_ENZA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ricardo Pereira Mestre
Lead Sponsor Class:
OTHER
Responsible Party:
Ricardo Pereira Mestre
Responsible Party Title:
MD
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ente Ospedaliero Cantonale Bellinzona
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Institute for Research in Biomedicine | UNKNOWN |
| Oncology Institute of Southern Switzerland | OTHER |
| Institute of Oncology Research | UNKNOWN |